Medifast Q4 revenue falls 37% to $75.1M; net loss $18.1M, guides FY26 rev $270-300M

MEDIFAST INC

2025-FY EPS reported -$1.70 revenue$385,788,000

Revenue $75.1M, down 36.9% YoY; active earning coaches down 40.6% to 16,100.
Net loss $18.1M ($1.65 EPS) includes $12.1M non-cash tax valuation allowance ($1.10/sh).
Full year 2025 revenue $385.8M (-36% YoY); net loss $18.7M (-$1.70 EPS).
Guides Q1 2026 rev $65-80M, loss $0.15-$0.70/sh; FY26 rev $270-300M, loss $1.55-$2.75/sh.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.